Jubilant Pharmova Limited (JUBLPHARMA) - Total Liabilities

Latest as of September 2025: Rs69.50 Billion INR ≈ $751.56 Million USD

Based on the latest financial reports, Jubilant Pharmova Limited (JUBLPHARMA) has total liabilities worth Rs69.50 Billion INR (≈ $751.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Jubilant Pharmova Limited operating cash flow efficiency to assess how effectively this company generates cash.

Jubilant Pharmova Limited - Total Liabilities Trend (2004–2025)

This chart illustrates how Jubilant Pharmova Limited's total liabilities have evolved over time, based on quarterly financial data. Check Jubilant Pharmova Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Jubilant Pharmova Limited Competitors by Total Liabilities

The table below lists competitors of Jubilant Pharmova Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Oculis Holding AG Ordinary shares NASDAQ:OCS	USA	$37.24 Million
Jangho Group Co Ltd SHG:601886	China	CN¥20.87 Billion
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd SHE:002100	China	CN¥8.05 Billion
Yutong Optical SHE:300790	China	CN¥3.30 Billion
Diversified Healthcare Trust NASDAQ:DHC	USA	$3.00 Billion
Jiangsu Expressway Company Limited F:JE2	Germany	€44.02 Billion
Systemair AB ST:SYSR	Sweden	Skr4.15 Billion
BlueNord ASA OL:BNOR	Norway	Nkr2.57 Billion

Liability Composition Analysis (2004–2025)

This chart breaks down Jubilant Pharmova Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see JUBLPHARMA stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.66	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jubilant Pharmova Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jubilant Pharmova Limited (2004–2025)

The table below shows the annual total liabilities of Jubilant Pharmova Limited from 2004 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs65.18 Billion ≈ $704.88 Million	+6.37%
2024-03-31	Rs61.27 Billion ≈ $662.66 Million	+6.29%
2023-03-31	Rs57.65 Billion ≈ $623.45 Million	+23.33%
2022-03-31	Rs46.74 Billion ≈ $505.53 Million	+11.92%
2021-03-31	Rs41.77 Billion ≈ $451.68 Million	-39.63%
2020-03-31	Rs69.18 Billion ≈ $748.13 Million	+3.88%
2019-03-31	Rs66.59 Billion ≈ $720.20 Million	+19.29%
2018-03-31	Rs55.83 Billion ≈ $603.74 Million	-1.09%
2017-03-31	Rs56.44 Billion ≈ $610.37 Million	-6.52%
2016-03-31	Rs60.37 Billion ≈ $652.93 Million	-2.29%
2015-03-31	Rs61.79 Billion ≈ $668.20 Million	+1.69%
2014-03-31	Rs60.76 Billion ≈ $657.11 Million	+4.29%
2013-03-31	Rs58.26 Billion ≈ $630.07 Million	+6.96%
2012-03-31	Rs54.47 Billion ≈ $589.09 Million	+1.82%
2011-03-31	Rs53.50 Billion ≈ $578.56 Million	+16.67%
2010-03-31	Rs45.85 Billion ≈ $495.88 Million	-14.07%
2009-03-31	Rs53.36 Billion ≈ $577.07 Million	+80.69%
2008-03-31	Rs29.53 Billion ≈ $319.38 Million	+26.36%
2007-03-31	Rs23.37 Billion ≈ $252.75 Million	+93.04%
2006-03-31	Rs12.11 Billion ≈ $130.93 Million	+59.66%
2005-03-31	Rs7.58 Billion ≈ $82.00 Million	+14.92%
2004-03-31	Rs6.60 Billion ≈ $71.36 Million	--

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.59 Billion

Rs146.75 Billion INR

Market Cap Rank

#7149 Global

#326 in India

Share Price

Rs926.60

Change (1 day)

-0.03%

52-Week Range

Rs807.65 - Rs1236.30

All Time High

Rs1269.00